Thus, the reduced expression of SREBP-1c can be considered as down-regulating the expression of its downstream gene SCD1, thus reducing lipid biosynthesis and alleviating NAFLD. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.